Radiotherapy Treatments for Neoplasms in the Abdominal-pelvic Region

Last updated: August 2, 2024
Sponsor: European Institute of Oncology
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pelvic Cancer

Abdominal Cancer

Peritoneal Cancer

Treatment

N/A

Clinical Study ID

NCT06335238
IEO 0729
  • Ages > 18
  • All Genders

Study Summary

Evaluation of clinical and dosimetric aspects, tolerance, and effectiveness of abdominal-pelvic region radiotherapy treatments in patients undergoing radiotherapy for primary or secondary neoplasms localized in the abdominal-pelvic region.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Patients treated with radiotherapy for curative, palliative, neo-adjuvant, andadjuvant purposes in the abdominal-pelvic region for: Primary tumors of the gastrointestinal tract, Primary tumors of the male and femalereproductive systems, Primary tumors of the urinary system, Primary tumors of thecardio-circulatory system, Primary tumors of the lymphatic system, Primary tumors ofthe nervous system, Skin tumors, Secondary abdominal-pelvic localizations of variousorigins, Primary or secondary bone or soft tissue lesions of the lumbosacral spineand pelvis.

  2. Signed informed consent

Exclusion

Exclusion Criteria:

  1. Radiotherapy in districts other than the abdominal-pelvic region

Study Design

Total Participants: 7700
Study Start date:
February 22, 2018
Estimated Completion Date:
December 31, 2024

Study Description

Approximately 60% of patients with neoplasms receive radiotherapy as part of their oncological treatment.

Various primary tumors as well as metastases of various origins can be localized in the abdominal-pelvic anatomical region.

Patients with such neoplastic localizations will therefore receive radiotherapy treatment possibly associated with other systemic or surgical treatments. Treatment choice is usually established following multidisciplinary discussions, based on disease characteristics and stage, concurrent pathologies and pharmacological treatments, patient preferences, and functional aspects.

Data collection related to radiotherapy plays a crucial role in understanding various clinical aspects of the treatment itself. The availability of data from an increasing number of patients will allow the identification of clinical situations or technical parameters of radiotherapy correlated with treatment tolerance and effectiveness, aiming to identify the best treatment for these oncological pathologies.

This project aims to collect data related to radiotherapy treatments for primary or secondary neoplasms of the abdominal-pelvic region for scientific dissemination with the goal of establishing the basis for evaluating achieved results over time, and deriving from these elements useful for guiding the most effective treatment strategies and appropriate operational protocols.

Connect with a study center

  • European Institute of Oncology

    Milan,
    Italy

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.